CNP acts as Singapore counsel to the Link Healthcare Group on its acquisition by Clinigen Plc.

Deals and cases

CNP acts as Singapore counsel to the Link Healthcare Group on its acquisition by Clinigen Plc.

Tuesday 3 November 2015

Colin Ng & Partners LLP (“CNP“) acted as Singapore counsel for Link Healthcare (“Link“), a specialist pharmaceutical and medical technology business focussed on the Asian, African and Australasian (“AAA“) regions, on the sale of Link to Clinigen Group plc (“Clinigen“), the specialty global pharmaceutical company listed in the UK, for an initial consideration of £44.5 million and a maximum of approximately £100 million based on achievement of milestones.

Clinigen agreed to acquire Link in late September 2015 and the acquisition was completed on 30 October 2015. CNP Partners Bill Jamieson and Amit Dhume advised Link